These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
554 related articles for article (PubMed ID: 20381651)
1. Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention. Verouden NJ; Haeck JD; Kuijt WJ; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; van Straalen JP; Fischer J; Piek JJ; Tijssen JG; de Winter RJ Am J Cardiol; 2010 Apr; 105(8):1047-52. PubMed ID: 20381651 [TBL] [Abstract][Full Text] [Related]
2. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654 [TBL] [Abstract][Full Text] [Related]
3. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels. Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726 [TBL] [Abstract][Full Text] [Related]
4. Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement. Lazzeri C; Chiostri M; Sori A; Valente S; Gensini GF J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):7-13. PubMed ID: 19829142 [TBL] [Abstract][Full Text] [Related]
5. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial). Bonaca MP; Wiviott SD; Sabatine MS; Buros J; Murphy SA; Scirica BM; Rifai N; Antman EM; Morrow DA Am J Cardiol; 2007 Feb; 99(3):344-8. PubMed ID: 17261395 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy). James SK; Lindahl B; Timmer JR; Ottervanger JP; Siegbahn A; Stridsberg M; Armstrong P; Califf R; Wallentin L; Simoons ML Am J Cardiol; 2006 Jan; 97(2):167-72. PubMed ID: 16442356 [TBL] [Abstract][Full Text] [Related]
7. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention. Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ; Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115 [TBL] [Abstract][Full Text] [Related]
8. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction. Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611 [TBL] [Abstract][Full Text] [Related]
10. Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention. de Winter RJ; Stroobants A; Koch KT; Bax M; Schotborgh CE; Mulder KJ; Sanders GT; van Straalen JP; Fischer J; Tijssen JG; Piek JJ Am J Cardiol; 2004 Dec; 94(12):1481-5. PubMed ID: 15589000 [TBL] [Abstract][Full Text] [Related]
11. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385 [TBL] [Abstract][Full Text] [Related]
12. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome. Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034 [TBL] [Abstract][Full Text] [Related]
14. Usefulness of preprocedural serum N-terminal pro-brain natriuretic peptide levels to predict long-term outcome after percutaneous coronary intervention in patients with normal troponin T levels. Saleh N; Braunschweig F; Jensen J; Tornvall P Am J Cardiol; 2006 Mar; 97(6):830-4. PubMed ID: 16516584 [TBL] [Abstract][Full Text] [Related]
15. Potential significance of spontaneous and interventional ST-changes in patients transferred for primary percutaneous coronary intervention: observations from the ST-MONitoring in Acute Myocardial Infarction study (The MONAMI study). Terkelsen CJ; Nørgaard BL; Lassen JF; Poulsen SH; Gerdes JC; Sloth E; Gøtzsche LB; Rømer FK; Thuesen L; Nielsen TT; Andersen HR Eur Heart J; 2006 Feb; 27(3):267-75. PubMed ID: 16227311 [TBL] [Abstract][Full Text] [Related]
16. NT pro-B-type natriuretic peptide levels are related to microvascular reperfusion in patients undergoing direct percutaneous transluminal coronary angioplasty for anterior ST-segment elevation myocardial infarction. Rossetti E; Mariani M; Poli A; Palmerini T; Finazzi S; Lotzniker M; Sangiorgi D; De Servi S J Cardiovasc Med (Hagerstown); 2010 May; 11(5):359-64. PubMed ID: 20051875 [TBL] [Abstract][Full Text] [Related]
17. Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplasty. Grabowski M; Filipiak KJ; Karpinski G; Wretowski D; Rdzanek A; Huczek Z; Horszczaruk GJ; Kochman J; Rudowski R; Opolski G Am Heart J; 2004 Oct; 148(4):655-62. PubMed ID: 15459597 [TBL] [Abstract][Full Text] [Related]
18. Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery. Goei D; Schouten O; Boersma E; Welten GM; Dunkelgrun M; Lindemans J; van Gestel YR; Hoeks SE; Bax JJ; Poldermans D Am J Cardiol; 2008 Jan; 101(1):122-6. PubMed ID: 18157978 [TBL] [Abstract][Full Text] [Related]
19. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy. Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928 [TBL] [Abstract][Full Text] [Related]